Zimbabwe has declined a major American healthcare agreement valued at $367m (272 million pounds) spanning five years over Washington's request for confidential information.
The decision came to light following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson has since stated that the US was seeking genetic material for scientific study and profit but was not willing to guarantee the benefits from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged continued talks to find a agreement acceptable to both sides so the nation's vital HIV programme can proceed.
Wider Implications
This rejection follows a similar situation in Kenya, where a court blocked a similar health funding agreement following concerns were filed about the security of Kenyans' medical information.
After returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.
As per reports, 16 nations in Africa have so far signed similar agreements, representing over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our population if a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of bilateral health agreements were undermining frameworks previously set up via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a country provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage further dialogue with our American counterparts on how subsequent co-operation might be arranged in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
A leading public health body expressed it acknowledged the government's concerns, but urged that negotiations should continue since a large portion of the country's HIV programmes were funded by international support.
"Where specific concerns arise, such as those relating to information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it said.
The halted deal underscores the continuing challenges between accepting much-needed international aid and protecting local interests in an increasingly data-driven world.